Introduction: Pancreatic cancer is highly lethal, often diagnosed at a locally advanced or metastatic stage due to its difficulty in detection and relatively common clinical symptoms, such as abdominal pain and nausea. Although the World Health Organization (WHO) does not recommend population-wide screening due to the low incidence of this neoplasm, its high mortality rate draws attention, especially considering that even after surgical treatment, patients may not have a life expectancy beyond five years. In general, the disease manifests as a ductal adenocarcinoma, with resection being the most commonly used surgical technique. Objectives: This study aims to analyze pancreatic cancer and its territorial distribution in Brazil, as well as its trend over time. The objective is to contribute to a broader understanding of pancreatic tumors in the national context and to raise awareness among healthcare professionals about a condition that continuously affects populations worldwide, particularly the Brazilian population. Methods: This is a cross-sectional, retrospective, and descriptive epidemiological study based on the analysis of hospital morbidity data provided by the Brazilian Unified Health System’s Information Department (DATASUS). Hospitalization and mortality records for malignant neoplasms of the pancreas, organized by year and region of Brazil, were considered for the last ten years (2015–2024). The data were compiled and analyzed using Microsoft Excel 2016 for subsequent presentation. Results: Analysis of the database revealed a total of 133,807 hospitalizations due to malignant neoplasms of the pancreas in the country. A growing trend was observed, with an average annual increase of approximately 1,145 hospitalizations throughout the study period. Although deaths showed a slight reduction between 2020 and 2021, an average annual increase of approximately 157 deaths was also identified, evidencing a progressive rise in both hospitalizations and deaths related to pancreatic cancer. The Southeast region recorded the highest number of hospitalizations over the ten-year period, totaling 62,801 cases, while the North region had the lowest, with 4,060 records. However, despite the lower number of hospitalizations, the North stood out for having the highest lethality rate, indicating a greater proportion of deaths among patients hospitalized for this neoplasm. Conclusions: The analyzed data demonstrate a progressive increase in both hospitalizations and deaths from pancreatic cancer in Brazil over the past decade, highlighting the epidemiological relevance of this neoplasm. The regional disparities, particularly the high lethality rate in the North, underscore the need for public policies focused on equitable access to early diagnosis and appropriate treatment. Despite the lack of international population-wide screening guidelines, the findings of this study indicate the urgency for regional strategies that promote greater efficiency in case management, contributing to the reduction of mortality associated with this condition.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
